Cytologic phenotypes of B-cell acute lymphoblastic leukemia - A single center study

Iranian Journal of Allergy, Asthma and Immunology

Volumn 8, Issue 2, 2009, Pages 99-106

  Ramyar, Asghar ^a   Shafiei, Masoud ^a   Rezaei, Nima ^a   Asgarian Omran, Hossein ^a   Esfahani, Shadi Abdar ^a   Moazzami, Kasra ^a   Sarafnejad, Abdolfattah ^a   Aghamohammadi, Asghar ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute lymphoblastic leukemia; Immunophenotyping; Morphology

Indexed keywords

CD20 ANTIBODY; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANEMIA; ARTICLE; B CELL LEUKEMIA; BLOOD ANALYSIS; BONE MARROW; CANCER DIAGNOSIS; CANCER RISK; CELL STRUCTURE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOCHEMISTRY; CYTOLOGY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; INFANT; LYMPHOID PROGENITOR CELL; MALE; ONSET AGE; PHENOTYPE; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ANTIGENS, CD20; B-LYMPHOCYTE SUBSETS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOPHENOTYPING; MALE; NEPRILYSIN; PHENOTYPE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS;

EID: 70349432700     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bruchova H, Kalinova M, Brdicka R. Array-based analysis of gene expression in childhood acute lymphoblastic leukemia. Leuk Res 2004; 28(1):1-7. (Pubitemid 37433787)
2. Uckun FM, Sather H, Gaynon P, Arthur D, Nachman J, Sensel M, et al. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group. Leuk Lymphoma 1997; 27(5-6):445-457 (Pubitemid 28029906)
3. Bennett JM, Catovsky D, Daniel MT. Proposals for the classification of the acute leukaemias. British Journal of Haematology 1976; 33(4):451-458
4. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256(5517):495-497
5. Foa R, Vitale A. Towards an integrated classification of adult acute lymphoblastic leukemia. Rev Clin Exp Hematol 2002; 6(2):181-99; discussion 200-202 (Pubitemid 34887262)
6. Gomez E, San Miguel JF, Gonzalez M, Orfao A, Canizo MC, Moraleda JM, et al. The value of the immunological subtypes and individual markers compared to classical parameters in the prognosis of acute lymphoblastic leukemia. Hematol Oncol 1991; 9(1):33-42.
7. Pui CH, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993; 82(2):343-362
8. Consolini R, Legitimo A, Rondelli R, Guguelmi C, Barisone E, Lippi A, et al. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP). Haematologica 1998; 83(11):967-973 (Pubitemid 29039463)
9. Pui CH, Rivera GK, Hancock ML, Raimondi SC, Sandlund JT, Mahmoud HH, et al. Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia. Leukemia 1993; 7(1):35-40. (Pubitemid 23048918)
10. Pui CH. Childhood leukemias. N Engl J Med 1995; 332(24):1618-1630
11. Pui CH, Behm FG, Singh B, Rivera GK, Schell MJ, Roberts WM, et al. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 1990; 75(1):198-202. (Pubitemid 20031509)
12. Ludwig WD, Raghavachar A, Thiel E. Immunophenotypic classification of acute lymphoblastic leukaemia. Baillieres Clin Haematol 1994; 7(2):235-262 (Pubitemid 24229748)
13. Uckun FM, Gaynon P, Sather H, Arthur D, Trigg M, Tubergen D, et al. Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 1997; 89(7):2488-2493 (Pubitemid 27143296)
14. Hann IM, Richards SM, Eden OB, Hill FG. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party. Leukemia 1998; 12(8):1249-1255
15. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9(10):1783-1786
16. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) cooperative group. Br J Haematol 1976; 33(4):451-458
17. Foon KA, Gale RP. Immunologic classification of lymphoma and lymphoid leukemia. Blood Rev 1987; 1(2):77-88.
18. Foon KA, Todd RF, 3rd. Immunologic classification of leukemia and lymphoma. Blood 1986; 68(1):1-31.
19. Hokland P, Ritz J, Schlossman SF, Nadler LM. Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells. J Immunol 1985; 135(3):1746-1751 (Pubitemid 16245357)
20. Rolink A, Melchers F. Generation and regeneration of cells of the B-lymphocyte lineage. Curr Opin Immunol 1993; 5(2):207-217 (Pubitemid 23125294)
21. Noordzij JG, de Bruin-Versteeg S, Verkaik NS, Vossen JM, de Groot R, Bernatowska E, et al. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins. Blood 2002; 100(6):2145-2152 (Pubitemid 35001250)
22. Ghia P, ten Boekel E, Rolink AG, Melchers F. B-cell development: a comparison between mouse and man. Immunol Today 1998; 19(10):480-485
23. Pagnucco G, Vanelli L, Gervasi F. Multidimensional flow cytometry immunophenotyping of hematologic malignancy. Ann N Y Acad Sci 2002; 963:313-321 (Pubitemid 34721724)
24. Dakka N, Bellaoui H, Khattab M, Brahimi-Horn MC, Aoued L, Bouzid N, et al. Immunologic profile and outcome of childhood acute lymphoblastic leukemia (ALL) in Morocco. J Pediatr Hematol Oncol 2007; 29(8):574-580 (Pubitemid 47356814)
25. Pui CH, Boyett JM, Relling MV, Harrison PL, Rivera GK, Behm FG, et al. Sex differences in prognosis for children with acute lymphoblastic leukemia. J Clin Oncol 1999; 17(3):818-824 (Pubitemid 29109311)
26. Brown LC, Knox-Macaulay HH. Analysis of the immunophenotypes of de novo acute lymphoblastic leukaemia (ALL) in the Sultanate of Oman. Leuk Res 2003; 27(7):649-654
27. Lilleyman JS, Hann IM, Stevens RF, Eden OB, Richards SM. French American British (FAB) morphological classification of childhood lymphoblastic leukaemia and its clinical importance. J Clin Pathol 1986; 39(9):998-1002.
28. Bene MC. Immunophenotyping of acute leukaemias. Immunol Lett 2005; 98(1):9-21.
29. Boucheix C, David B, Sebban C, Racadot E, Bene MC, Bernard A, et al. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia. Blood 1994; 84(5):1603-1612 (Pubitemid 24273031)
30. Paredes-Aguilera R, Romero-Guzman L, Lopez-Santiago N, Burbano-Ceron L, Camacho-Del Monte O, Nieto-Martinez S. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia. Am J Hematol 2001; 68(2):69-74. (Pubitemid 32844864)
31. Taskov H, Dimitrova E, Serbinova M, Mendisova L, Bobev D. Immunological subtypes of childhood acute lymphoblastic leukemia in Bulgaria. Leuk Res 1995; 19(11):877-881 (Pubitemid 26009458)
32. Wiwanitkit V. A summary on the immunophenotyping of acute lymphoblastic leukemia in Thailand. Hematology 2005; 10(1):35-37 (Pubitemid 41093586)
33. Kamat DM, Gopal R, Advani SH, Nair CN, Kumar A, Saikia T, et al. Pattern of subtypes of acute lymphoblastic leukemia in India. Leuk Res 1985; 9(7):927-934 (Pubitemid 15030822)